These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 20816920)
1. Mutational analysis of GIGYF2, ATP13A2 and GBA genes in Brazilian patients with early-onset Parkinson's disease. Dos Santos AV; Pestana CP; Diniz KR; Campos M; Abdalla-Carvalho CB; de Rosso AL; Pereira JS; Nicaretta DH; de Carvalho WL; Dos Santos JM; Santos-Rebouças CB; Pimentel MM Neurosci Lett; 2010 Nov; 485(2):121-4. PubMed ID: 20816920 [TBL] [Abstract][Full Text] [Related]
2. Lysosomal defects in ATP13A2 and GBA associated familial Parkinson's disease. Sato S; Li Y; Hattori N J Neural Transm (Vienna); 2017 Nov; 124(11):1395-1400. PubMed ID: 28894968 [TBL] [Abstract][Full Text] [Related]
3. Association between Parkinson's disease and glucocerebrosidase mutations in Brazil. Spitz M; Rozenberg R; Pereira Lda V; Reis Barbosa E Parkinsonism Relat Disord; 2008; 14(1):58-62. PubMed ID: 17703984 [TBL] [Abstract][Full Text] [Related]
4. Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease. Clark LN; Ross BM; Wang Y; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K Neurology; 2007 Sep; 69(12):1270-7. PubMed ID: 17875915 [TBL] [Abstract][Full Text] [Related]
5. Heterozygous GBA D409V and ATP13a2 mutations do not exacerbate pathological α-synuclein spread in the prodromal preformed fibrils model in young mice. Johnson ME; Bergkvist L; Stetzik L; Steiner JA; Meyerdirk L; Schulz E; Wolfrum E; Luk KC; Wesson DW; Krainc D; Brundin P Neurobiol Dis; 2021 Nov; 159():105513. PubMed ID: 34536552 [TBL] [Abstract][Full Text] [Related]
6. Analysis of the glucocerebrosidase gene in Parkinson's disease. Sato C; Morgan A; Lang AE; Salehi-Rad S; Kawarai T; Meng Y; Ray PN; Farrer LA; St George-Hyslop P; Rogaeva E Mov Disord; 2005 Mar; 20(3):367-70. PubMed ID: 15517592 [TBL] [Abstract][Full Text] [Related]
7. Mutations in the glucocerebrosidase gene are common in patients with Parkinson's disease from Eastern Canada. Han F; Grimes DA; Li F; Wang T; Yu Z; Song N; Wu S; Racacho L; Bulman DE Int J Neurosci; 2016; 126(5):415-21. PubMed ID: 26000814 [TBL] [Abstract][Full Text] [Related]
8. β-Glucocerebrosidase gene mutations in two cohorts of Greek patients with sporadic Parkinson's disease. Moraitou M; Hadjigeorgiou G; Monopolis I; Dardiotis E; Bozi M; Vassilatis D; Vilageliu L; Grinberg D; Xiromerisiou G; Stefanis L; Michelakakis H Mol Genet Metab; 2011; 104(1-2):149-52. PubMed ID: 21745757 [TBL] [Abstract][Full Text] [Related]
9. Mutations in glucocerebrosidase are a major genetic risk factor for Parkinson's disease and increase susceptibility to dementia in a Flanders-Belgian cohort. Crosiers D; Verstraeten A; Wauters E; Engelborghs S; Peeters K; Mattheijssens M; De Deyn PP; Theuns J; Van Broeckhoven C; Cras P Neurosci Lett; 2016 Aug; 629():160-164. PubMed ID: 27397011 [TBL] [Abstract][Full Text] [Related]
10. Homozygosity for the MTX1 c.184T>A (p.S63T) alteration modifies the age of onset in GBA-associated Parkinson's disease. Gan-Or Z; Bar-Shira A; Gurevich T; Giladi N; Orr-Urtreger A Neurogenetics; 2011 Nov; 12(4):325-32. PubMed ID: 21837367 [TBL] [Abstract][Full Text] [Related]
11. Association of mutations in the glucocerebrosidase gene with Parkinson disease in a Korean population. Choi JM; Kim WC; Lyoo CH; Kang SY; Lee PH; Baik JS; Koh SB; Ma HI; Sohn YH; Lee MS; Kim YJ Neurosci Lett; 2012 Apr; 514(1):12-5. PubMed ID: 22387070 [TBL] [Abstract][Full Text] [Related]
12. Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Greece. Kalinderi K; Bostantjopoulou S; Paisan-Ruiz C; Katsarou Z; Hardy J; Fidani L Neurosci Lett; 2009 Mar; 452(2):87-9. PubMed ID: 19383421 [TBL] [Abstract][Full Text] [Related]
13. Analysis of Thr12Met and Ala1144Thr mutations of the ATP13A2 gene in Parkinson's disease patients in Xinjiang Uygur and Han ethnic groups. Li G; Zhang Z; Xia H; Yang X Med Sci Monit; 2014 Nov; 20():2177-82. PubMed ID: 25374329 [TBL] [Abstract][Full Text] [Related]
14. An assessment of the frequency of mutations in the GBA and VPS35 genes in Hungarian patients with sporadic Parkinson's disease. Török R; Zádori D; Török N; Csility É; Vécsei L; Klivényi P Neurosci Lett; 2016 Jan; 610():135-8. PubMed ID: 26547032 [TBL] [Abstract][Full Text] [Related]
15. Mutations of glucocerebrosidase gene and susceptibility to Parkinson's disease: An updated meta-analysis in a European population. Zhao F; Bi L; Wang W; Wu X; Li Y; Gong F; Lu S; Feng F; Qian Z; Hu C; Wu Y; Sun Y Neuroscience; 2016 Apr; 320():239-46. PubMed ID: 26868973 [TBL] [Abstract][Full Text] [Related]
16. Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease. Benitez BA; Davis AA; Jin SC; Ibanez L; Ortega-Cubero S; Pastor P; Choi J; Cooper B; Perlmutter JS; Cruchaga C Mol Neurodegener; 2016 Apr; 11():29. PubMed ID: 27094865 [TBL] [Abstract][Full Text] [Related]
17. Mutations in the ATP13A2 gene and Parkinsonism: a preliminary review. Yang X; Xu Y Biomed Res Int; 2014; 2014():371256. PubMed ID: 25197640 [TBL] [Abstract][Full Text] [Related]
18. Genetic analysis of ATP13A2, PLA2G6 and FBXO7 in a cohort of Chinese patients with early-onset Parkinson's disease. Shen T; Pu J; Lai HY; Xu L; Si X; Yan Y; Jiang Y; Zhang B Sci Rep; 2018 Sep; 8(1):14028. PubMed ID: 30232368 [TBL] [Abstract][Full Text] [Related]
19. Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort. Winder-Rhodes SE; Evans JR; Ban M; Mason SL; Williams-Gray CH; Foltynie T; Duran R; Mencacci NE; Sawcer SJ; Barker RA Brain; 2013 Feb; 136(Pt 2):392-9. PubMed ID: 23413260 [TBL] [Abstract][Full Text] [Related]